Key result
Calcium-modifying device use rises ~70% across Belgian PCI centers, driven by cutting and scoring balloons.
Why the study?
Adoption of calcium-modifying devices in PCI is shaped by recommendations, evidence, reimbursement policy, and local practice, motivating an evaluation of utilization trends across Belgium.
Observational
Yes
This three-year national survey demonstrates a 70% increase in calcium-modifying device usage during PCI across Belgium from 2023 to 2025—primarily driven by cutting/scoring balloons and rotational atherectomy—while highlighting an approximately 48-fold variation in utilization across centres.
Answers are grounded in this paper and cite their sources.
Substantial inter-center variation in calcium-modifying device use warrants caution against unchecked adoption; leaves open optimal indications and outcome impact.
BACKGROUND: Adoption of calcium-modifying devices in percutaneous coronary intervention (PCI) is shaped by international recommendations, published evidence, national reimbursement policy, and local catheterisation-laboratory practice, all of which influence the distribution of these technologies. AIMS: To evaluate the adoption of calcium-modifying devices across Belgium through a national survey. METHODS AND RESULTS: Procedural data on total PCI volume and six calcium-modifying devices - rotational and orbital atherectomy, intravascular lithotripsy, cutting, scoring, and super-high-pressure balloons - were collected from 26 Belgian catheterisation laboratories (Belgian Calcium Survey) over three consecutive years (2023-2025). Centre-level and survey-wide usage rates were calculated annually and benchmarked against international registries. Total device-use instances increased by approximately 70%, from 2,418 in 2023 to 4,136 in 2025, against an essentially unchanged PCI volume. The increase was driven predominantly by cutting and scoring balloons (85% of additional instances), with a smaller rise in rotational atherectomy; orbital atherectomy remained marginal (4/26 centres). Between-centre use was highly variable, spanning approximately 48-fold. Rotational atherectomy was concentrated in a minority of centres, with the 5 highest-volume centres performing 47-49% of national volume. CONCLUSIONS: Calcium-modifying device use increased substantially across Belgium between 2023 and 2025, driven mainly by cutting balloons and rotational atherectomy, possibly accelerated by the 2024 reimbursement change for the latter. Distribution across centres was highly variable. Atherectomy use rates remained within the range reported by international registries. Imaging-guided device selection may improve consistency of use, as current evidence provides no single gold-standard solution and available technologies continue to expand.
No takes yet. Share an insight, caveat, or question.
Ungureanu et al. (2026) conducted an observational in Calcified coronary artery disease undergoing percutaneous coronary intervention. Calcium-modifying devices (rotational and orbital atherectomy, intravascular lithotripsy, cutting, scoring, and super-high-pressure balloons) was evaluated on Adoption and annual usage rates of calcium-modifying devices. Calcium-modifying device use in Belgium increased by ~70% from 2,418 instances in 2023 to 4,136 in 2025, driven mainly by cutting and scoring balloons.
Synapse has enriched 10 related papers. Consider them for comparative context: